Last Updated on Tuesday, 24 November, 2020 at 9:03 pm by Andre Camilleri
Malta’s fastest growing science company has signed a ‘landmark’ deal to further develop the medical cannabis industry on the island and overseas.
Evolve has joined forces with two specialist medical cannabis firms, Malta and UK-based Cannanalytica and Cannabreeze from Greece, to better serve customer needs and provide a single point of contact with overall responsibility.
Cannanalytica offers regulatory, EU-GMP certification and business development consultancy services to investors and licensed producers who are currently present or planning to enter the medical cannabis space.
Meanwhile, the Cannabreeze team provides a full 360° in-depth innovative approach in consultation and equipment, from medical cannabis cultivation to processing facilities.
The collaboration will see all three companies working together on major medical cannabis projects, in the region, with each focusing on their fields of expertise from technical knowledge to cultivation and packaging.
Evolve has a proven record of success in the field, having helped to develop the first EU-GMP-compliant medical cannabis facilities in Malta in 2019.
The Luqa-based company is also the leading turnkey contractor for any other part of the investment, be it cleanrooms, lab equipment and supplies or even purified water loops.
Evolve managing director Christopher Busuttil Delbridge said: ‘With this cooperation agreement the pains of planning and setting up the facilities required are gone and taken on by our newly-formed venture.
‘Together, we have decades of experience in the industry, and this joint project will allow investors and growers to move directly to what they want to do and are good at, reaping the fruits of their efforts.
‘The future is bright for anyone setting up operations in this industry and this partnership has just made it easier.’